ALCIDION GROUP LIMITED — Capital/Financing Update 2021

Dec 14, 2021

==> picture [167 x 44] intentionally omitted <==

15 December 2021

Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000

Notice under section 708A(5)(e) of the Corporations Act

Melbourne, Victoria - This notice is given by Alcidion Group Limited (ASX:ALC) ( Alcidion ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

The Company hereby confirms that:

• a) it has today issued 120,183,900 fully paid ordinary share at an issue price of $0.25 (25 cents) per share to professional and sophisticated investors in relation to the Placement announced 7 December 2021.

• b) the shares referred to in paragraph (a) above were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

• c) it is providing this notice under paragraph 5(e) of Section 708A of the Corporations Act;

• d) as at the date of this notice the Company, as a disclosing entity under the Corporations Act, has complied with:

  • (i) the provisions of Chapter 2M of the Corporations Act as they apply to Alcidion; and

  • (ii) section 674 of the Corporations Act; and

• e) as at the date of this notice, there is no excluded information of the type referred to in subsections 708A(7) and 708A(8) of the Corporations Act.

ENDS

For and on behalf of the Board:

For further information, please contact:

Melanie Leydin

Company Secretary Ph: +61 3 9692 7222

Kerstin Wahlqvist

Investor Relations Manager Ph: +61 402 088 303 kersten.wahlqvist@alcidion.com

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [167 x 44] intentionally omitted <==

About Alcidion

Alcidion Limited (ASX:ALC) has a simple purpose: to transform healthcare with smart, intuitive technology solutions that meet the needs of hospital and allied healthcare, worldwide. It offers a complementary set of software products and services that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. In 2017 Alcidion acquired Oncall System and its Smartpage clinical communication system. In 2018 it acquired the Patientrack bedside patient monitoring software and MKM Health, an IT solutions and services provider. These offerings now operate under the Alcidion brand. With over 25 years of combined healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

© Alcidion Group Limited 2019. Alcidion, MKM Health, Miya, Patientrack and Smartpage are registered trademarks. All other brands and product names and trademarks are the registered property of their respective companies.

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com